SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Xue Shanyan)
 

Sökning: WFRF:(Xue Shanyan) > (2010) > Population-Based St...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004200naa a2200493 4500
001oai:lup.lub.lu.se:67190f37-9d28-4232-9d9f-4966a35d83cd
003SwePub
008160404s2010 | |||||||||||000 ||eng|
024a https://lup.lub.lu.se/record/15955682 URI
024a https://doi.org/10.1200/JCO.2009.24.24952 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
100a Malone, Kathleen E4 aut
2451 0a Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2.
264 1c 2010
520 a PURPOSE: Women with breast cancer diagnosed early in life comprise a substantial portion of those tested for BRCA1/BRCA2 mutations; however, little information is available on the subsequent risks of contralateral breast cancer in mutation carriers. This study assessed the risk of subsequent contralateral breast cancer associated with carrying a BRCA1 or BRCA2 mutation. PATIENTS AND METHODS: In this nested case-control study, patients with contralateral breast cancer diagnosed 1 year or more after a first primary breast cancer (n = 705) and controls with unilateral breast cancer (n = 1,398) were ascertained from an underlying population-based cohort of 52,536 women diagnosed with a first invasive breast cancer before age 55 years. Interviews and medical record reviews were used to collect risk factor and treatment histories. All women were tested for BRCA1/BRCA2 mutations. Relative (rate ratios) and absolute (5- and 10-year cumulative) risks of developing contralateral breast cancer following a first invasive breast cancer were computed. RESULTS: Compared with noncarriers, BRCA1 and BRCA2 mutation carriers had 4.5-fold (95% CI, 2.8- to 7.1-fold) and 3.4-fold (95% CI, 2.0- to 5.8-fold) increased risks of contralateral breast cancer, respectively. The relative risk of contralateral breast cancer for BRCA1 mutation carriers increased as age of first diagnosis decreased. Age-specific cumulative risks are provided for clinical guidance. CONCLUSION: The risks of subsequent contralateral breast cancer are substantial for women who carry a BRCA1/BRCA2 mutation. These findings have important clinical relevance regarding the assessment of BRCA1/BRCA2 status in patients with breast cancer and the counseling and clinical management of patients found to carry a mutation.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng
700a Begg, Colin B4 aut
700a Haile, Robert W4 aut
700a Borg, Åkeu Lund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)onk-abo
700a Concannon, Patrick4 aut
700a Tellhed, Linau Lund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)onk-ljo
700a Xue, Shanyan4 aut
700a Teraoka, Sharon4 aut
700a Bernstein, Leslie4 aut
700a Capanu, Marinela4 aut
700a Reiner, Anne S4 aut
700a Riedel, Elyn R4 aut
700a Thomas, Duncan C4 aut
700a Mellemkjær, Lene4 aut
700a Lynch, Charles F4 aut
700a Boice, John D4 aut
700a Anton-Culver, Hoda4 aut
700a Bernstein, Jonine L4 aut
710a Bröstcancer-genetikb Sektion I4 org
773t Journal of Clinical Oncologyg 28, s. 2404-2410q 28<2404-2410x 1527-7755
856u http://www.ncbi.nlm.nih.gov/pubmed/20368571?dopt=Abstracty FULLTEXT
856u http://dx.doi.org/10.1200/JCO.2009.24.2495y FULLTEXT
8564 8u https://lup.lub.lu.se/record/1595568
8564 8u https://doi.org/10.1200/JCO.2009.24.2495

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy